Putting Science to Work

Archives / 2018 / May

  • An Exclusive Interview with Jonathan Hunt – CEO, Syngene International, India by Pharma Boardroom

    Pharma Boardroom- 24/05/2018. Syngene International, one of the fastest growing and leading contract research and manufacturing organizations in the world, discusses the company’s unique ecosystem of innovation...

    .

  • Syngene International Q4 net rises 8% to Rs 84 crore

    Money Control-25/04/2018. During FY18, the company's net profit increased by 6 percent at Rs 305 crore and revenue by 17 percent at Rs 1,485 crore.

    .

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget